Mark Hatherill

17.1k citations
194 papers · 6.7k · 1 hit paper · h-index 45

Impact in

    • Tuberculosis Research and Epidemiology
  • Immunology top 1%
    • Immunodeficiency and Autoimmune Disorders
    • Immune responses and vaccinations

Papers in

    • Tuberculosis Research and Epidemiology 129
    • Mycobacterium research and diagnosis 49
    • Pneumonia and Respiratory Infections 25
    • Pneumocystis jirovecii pneumonia detection and treatment 18

Mark Hatherill

183 papers receiving 6.5k citations

Hit Papers

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial 2013 · 753 citations
7530+4+8Years since publication250500750

Peers

Mark Hatherill
Comparison fields: 5 of 140
  • Infectious Diseases 4.1k
  • Immunology 2.3k
  • Epidemiology 3.2k
  • Nephrology 410
  • Critical Care and Intensive Care Medicine 232
Replace Deepali Kumar with:
Deepali Kumar Canada
Maurizio de Martino Italy
Asunción Moreno Spain
Timothy L. Pruett United States
Michael G. Ison United States
Juan Gea‐Banacloche United States
Catherine Liu United States
Patricia Ribaud France
John W. Baddley United States
Annelies Verbon Netherlands
Mark Hatherill relative to Deepali Kumar Canada Deepali Kumar's profile →
Citations per field
00.5×4.4×
Deepali Kumar · 1×
Citations per year

Countries citing papers authored by Mark Hatherill

Since Specialization
Citations

This map shows the geographic impact of Mark Hatherill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Hatherill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Hatherill more than expected).

Fields of papers citing papers by Mark Hatherill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Hatherill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Hatherill. The network helps show where Mark Hatherill may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Hatherill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Hatherill Line = papers co-authored together Mark Hatherill links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 194 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
Hit paper breakdown →
2013753
2 2010324
3 1999207
4 1997159
5 2009148
6 2011146
7 2000135
8 2016134
9 2008133
10 1997118
11 2018114
12 1999113
13 2014112
14 2016106
15 199996
16 199795
17 201795
18 201594
19 201592
20 200892

About Mark Hatherill

Mark Hatherill is a scholar working on Infectious Diseases, Epidemiology, Surgery, Immunology and Nephrology, having authored 194 papers that have together received 6.7k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (129 papers), Mycobacterium research and diagnosis (49 papers), Immunodeficiency and Autoimmune Disorders (40 papers), Diagnosis and treatment of tuberculosis (30 papers), Immune responses and vaccinations (28 papers), Pneumonia and Respiratory Infections (25 papers), Infectious Diseases and Tuberculosis (23 papers) and Pneumocystis jirovecii pneumonia detection and treatment (18 papers). The work is most often cited by research in Infectious Diseases (4.1k citations), Immunology (2.3k citations), Epidemiology (3.2k citations), Nephrology (410 citations) and Critical Care and Intensive Care Medicine (232 citations). Mark Hatherill has collaborated with scholars based in South Africa, United States and United Kingdom. Frequent co-authors include Willem A. Hanekom, Thomas J. Scriba, Hassan Mahomed, Shane M. Tibby, Gregory Hussey, Michèle Tameris, IA Murdoch, Helen McShane, Charles Turner and J. Bruce McClain. Their work appears in journals such as PLoS ONE, Archives of Disease in Childhood, Vaccine, American Journal of Respiratory and Critical Care Medicine and Intensive Care Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact